Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2021 Filed Feb 19, 2021 00:24 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006562 · form4.xml · derivative · entry 6 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/17/2018. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/17/2018. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 00:24 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 868 | $19.97 | $17,333.96 |
DisclosureSEC source: 0001127602-21-006562 · form4.xml · nonDerivative · entry 4 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,769 Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 00:24 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006562 · form4.xml · nonDerivative · entry 3 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 00:23 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006561 · form4.xml · derivative · entry 6 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/17/2018. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/17/2018. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 00:23 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 868 | $19.97 | $17,333.96 |
DisclosureSEC source: 0001127602-21-006561 · form4.xml · nonDerivative · entry 4 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,763 Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 00:23 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006561 · form4.xml · nonDerivative · entry 3 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,631 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:28 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 18,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006566 · form4.xml · derivative · entry 5 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,125 Underlying: Ordinary Shares · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/16/2019. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/16/2019. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:28 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Tax withholdingOrdinary Shares | 8,074 | $19.79 | $159,784.46 |
DisclosureSEC source: 0001127602-21-006566 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 769,145 Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:28 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionOrdinary Shares | 18,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006566 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 777,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 19:27 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006565 · form4.xml · derivative · entry 5 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,375 Underlying: Ordinary Shares · 3,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/16/2019. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/16/2019. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 19:27 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 1,678 | $19.79 | $33,207.62 |
DisclosureSEC source: 0001127602-21-006565 · form4.xml · nonDerivative · entry 2 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,042 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 19:27 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 3,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006565 · form4.xml · nonDerivative · entry 1 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:26 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 2,375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006564 · form4.xml · derivative · entry 5 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,375 Underlying: Ordinary Shares · 2,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/16/2019. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/16/2019. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:26 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Tax withholdingOrdinary Shares | 825 | $19.79 | $16,326.75 |
DisclosureSEC source: 0001127602-21-006564 · form4.xml · nonDerivative · entry 2 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,082 Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:26 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionOrdinary Shares | 2,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006564 · form4.xml · nonDerivative · entry 1 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:25 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006563 · form4.xml · derivative · entry 3 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,375 Underlying: Ordinary Shares · 3,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/16/2019. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/16/2019. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:25 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Tax withholdingOrdinary Shares | 1,172 | $19.79 | $23,193.88 |
DisclosureSEC source: 0001127602-21-006563 · form4.xml · nonDerivative · entry 2 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,036 Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:25 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 3,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006563 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:24 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006562 · form4.xml · derivative · entry 5 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,375 Underlying: Ordinary Shares · 3,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/16/2019. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/16/2019. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:24 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 1,172 | $19.79 | $23,193.88 |
DisclosureSEC source: 0001127602-21-006562 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,137 Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:24 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 3,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006562 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:23 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 2,375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006561 · form4.xml · derivative · entry 5 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,375 Underlying: Ordinary Shares · 2,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/16/2019. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/16/2019. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:23 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 825 | $19.79 | $16,326.75 |
DisclosureSEC source: 0001127602-21-006561 · form4.xml · nonDerivative · entry 2 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,131 Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:23 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 2,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006561 · form4.xml · nonDerivative · entry 1 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 22:28 UTC |
MCKEON BRIAN PDirector
|
GrantRestricted Stock Unit Award · Derivative | 2,223 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005257 · form4.xml · derivative · entry 4 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,223 Underlying: Ordinary Shares · 2,223 shares Expires not disclosed F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 2/10/2022. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 2/10/2022. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 22:28 UTC |
MCKEON BRIAN PDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 4,549 | $0.00 Strike: $22.93 | $0.00 |
DisclosureSEC source: 0001127602-21-005257 · form4.xml · derivative · entry 3 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,549 Underlying: Ordinary Shares · 4,549 shares Expires 2031-02-10 F3 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 2/10/2022. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 22:28 UTC |
MCKEON BRIAN PDirector
|
GrantRestricted Stock Unit Award · Derivative | 13,336 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005257 · form4.xml · derivative · entry 2 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,336 Underlying: Ordinary Shares · 13,336 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in three annual installments commencing on 2/10/2022. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in three annual installments commencing on 2/10/2022. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 22:28 UTC |
MCKEON BRIAN PDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 26,169 | $0.00 Strike: $22.93 | $0.00 |
DisclosureSEC source: 0001127602-21-005257 · form4.xml · derivative · entry 1 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,169 Underlying: Ordinary Shares · 26,169 shares Expires 2031-02-10 F1 · derivative.exercise_date: Shares subject to the stock option award vest in three annual installments commencing on 2/10/2022. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 22:30 UTC |
Daglio David Angelo Jr.Director
|
GrantRestricted Stock Unit Award · Derivative | 2,223 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005259 · form4.xml · derivative · entry 4 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,223 Underlying: Ordinary Shares · 2,223 shares Expires not disclosed F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 2/10/2022. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 2/10/2022. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 22:30 UTC |
Daglio David Angelo Jr.Director
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 4,549 | $0.00 Strike: $22.93 | $0.00 |
DisclosureSEC source: 0001127602-21-005259 · form4.xml · derivative · entry 3 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,549 Underlying: Ordinary Shares · 4,549 shares Expires 2031-02-10 F3 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 2/10/2022. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 22:30 UTC |
Daglio David Angelo Jr.Director
|
GrantRestricted Stock Unit Award · Derivative | 13,336 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005259 · form4.xml · derivative · entry 2 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,336 Underlying: Ordinary Shares · 13,336 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in three annual installments commencing on 2/10/2022. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in three annual installments commencing on 2/10/2022. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 22:30 UTC |
Daglio David Angelo Jr.Director
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 26,169 | $0.00 Strike: $22.93 | $0.00 |
DisclosureSEC source: 0001127602-21-005259 · form4.xml · derivative · entry 1 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,169 Underlying: Ordinary Shares · 26,169 shares Expires 2031-02-10 F1 · derivative.exercise_date: Shares subject to the stock option award vest in three annual installments commencing on 2/10/2022. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 16:38 UTC |
DIXON WENDY LDirector
|
Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $12.62 | $0.00 |
DisclosureSEC source: 0001127602-21-001770 · form4.xml · derivative · entry 4 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 20,000 shares Expires 2021-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 16:38 UTC |
DIXON WENDY LDirector
|
Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $12.62 | $0.00 |
DisclosureSEC source: 0001127602-21-001770 · form4.xml · derivative · entry 3 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2021-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 16:38 UTC |
DIXON WENDY LDirector
|
Exercise / conversionOrdinary Shares | 20,000 | $12.62 | $252,400.00 |
DisclosureSEC source: 0001127602-21-001770 · form4.xml · nonDerivative · entry 2 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 16:38 UTC |
DIXON WENDY LDirector
|
Exercise / conversionOrdinary Shares | 15,000 | $12.62 | $189,300.00 |
DisclosureSEC source: 0001127602-21-001770 · form4.xml · nonDerivative · entry 1 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 16:28 UTC |
ANSTICE DAVID WDirector
|
GrantRestricted Stock Unit Award · Derivative | 5,578 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030565 · form4.xml · derivative · entry 2 ANSTICE DAVID W · CIK 0001181171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,578 Underlying: Ordinary Shares · 5,578 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 16:28 UTC |
ANSTICE DAVID WDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 11,509 | $0.00 Strike: $18.82 | $0.00 |
DisclosureSEC source: 0001127602-20-030565 · form4.xml · derivative · entry 1 ANSTICE DAVID W · CIK 0001181171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,509 Underlying: Ordinary Shares · 11,509 shares Expires 2030-12-02 F1 · derivative.exercise_date: This option becomes exercisable in full on 12/2/2021. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 21:38 UTC |
Wilson Frank AndersDirector
|
GrantRestricted Stock Unit Award · Derivative | 5,578 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030581 · form4.xml · derivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,578 Underlying: Ordinary Shares · 5,578 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 21:38 UTC |
Wilson Frank AndersDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 11,509 | $0.00 Strike: $18.82 | $0.00 |
DisclosureSEC source: 0001127602-20-030581 · form4.xml · derivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,509 Underlying: Ordinary Shares · 11,509 shares Expires 2030-12-02 F1 · derivative.exercise_date: This option becomes exercisable in full on 12/2/2021. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 21:39 UTC |
Wysenski NancyDirector
|
GrantRestricted Stock Unit Award · Derivative | 5,578 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030583 · form4.xml · derivative · entry 2 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,578 Underlying: Ordinary Shares · 5,578 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 21:39 UTC |
Wysenski NancyDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 11,509 | $0.00 Strike: $18.82 | $0.00 |
DisclosureSEC source: 0001127602-20-030583 · form4.xml · derivative · entry 1 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,509 Underlying: Ordinary Shares · 11,509 shares Expires 2030-12-02 F1 · derivative.exercise_date: This option becomes exercisable in full on 12/2/2021. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 16:29 UTC |
BREYER ROBERT ADirector
|
GrantRestricted Stock Unit Award · Derivative | 5,578 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030567 · form4.xml · derivative · entry 2 BREYER ROBERT A · CIK 0001236441 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,578 Underlying: Ordinary Shares · 5,578 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 16:29 UTC |
BREYER ROBERT ADirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 11,509 | $0.00 Strike: $18.82 | $0.00 |
DisclosureSEC source: 0001127602-20-030567 · form4.xml · derivative · entry 1 BREYER ROBERT A · CIK 0001236441 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,509 Underlying: Ordinary Shares · 11,509 shares Expires 2030-12-02 F1 · derivative.exercise_date: This option becomes exercisable in full on 12/2/2021. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 16:34 UTC |
MITCHELL PAUL JDirector
|
GrantRestricted Stock Unit Award · Derivative | 5,578 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030578 · form4.xml · derivative · entry 2 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,578 Underlying: Ordinary Shares · 5,578 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 16:34 UTC |
MITCHELL PAUL JDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 11,509 | $0.00 Strike: $18.82 | $0.00 |
DisclosureSEC source: 0001127602-20-030578 · form4.xml · derivative · entry 1 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,509 Underlying: Ordinary Shares · 11,509 shares Expires 2030-12-02 F1 · derivative.exercise_date: This option becomes exercisable in full on 12/2/2021. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 16:32 UTC |
DIXON WENDY LDirector
|
GrantRestricted Stock Unit Award · Derivative | 5,578 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030574 · form4.xml · derivative · entry 2 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,578 Underlying: Ordinary Shares · 5,578 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 16:32 UTC |
DIXON WENDY LDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 11,509 | $0.00 Strike: $18.82 | $0.00 |
DisclosureSEC source: 0001127602-20-030574 · form4.xml · derivative · entry 1 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,509 Underlying: Ordinary Shares · 11,509 shares Expires 2030-12-02 F1 · derivative.exercise_date: This option becomes exercisable in full on 12/2/2021. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 21:35 UTC |
snyderman nancy lynn MDDirector
|
GrantRestricted Stock Unit Award · Derivative | 5,578 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030579 · form4.xml · derivative · entry 2 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,578 Underlying: Ordinary Shares · 5,578 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 21:35 UTC |
snyderman nancy lynn MDDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 11,509 | $0.00 Strike: $18.82 | $0.00 |
DisclosureSEC source: 0001127602-20-030579 · form4.xml · derivative · entry 1 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,509 Underlying: Ordinary Shares · 11,509 shares Expires 2030-12-02 F1 · derivative.exercise_date: This option becomes exercisable in full on 12/2/2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.